Beta-blockers have been the initial treatment for symptomatic obstructive hypertrophic cardiomyopathy (HCM) despite limited evidence of their efficacy. Aficamten is a cardiac myosin inhibitor that ...
London, UK - The Carvedilol or Metoprolol European Trial (COMET) trial, showing improved survival with carvedilol over metoprolol, has now been published in the July 5, 2003 issue of the Lancet. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback